ACT Melanoma Abstract Presentations

Saturday, March 12, 2022

8:00 AM – 9:40 AM CST

Location:Chantilly West

Moderator(s)

Ashley Holder, MD

Assistant Professor
University of Alabama at Birmingham
Birmingham, Alabama, United States
Michael Egger, MD, MPH

Assistant Professor
Unversity of Louisville
Louisville, KY, United States

Participants should be aware of the following financial/non-financial relationships:

Ashley M. Holder, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Michael E. Egger, MD, MPH: Iovance Biotherapeutics (Individual(s) Involved: Self): Consultant; SkylineDx (Individual(s) Involved: Self): Research Support

Presentations:

8:01 AM – 8:09 AM CST

A13: In-transit Melanoma: A Multi-institutional Analysis of Outcomes
Abstract Presenter: Danielle M. Bello, MD – Memorial Sloan Kettering Cancer Center
8:09 AM – 8:11 AM CST

A13: Q&A
Abstract Presenter: Danielle M. Bello, MD – Memorial Sloan Kettering Cancer Center
8:11 AM – 8:19 AM CST

A10: Cancer Vaccine Plus Intratumoral IFNγ or Topical TLR7 Agonist Promote Vaccine-induced T Cell Infiltration of Melanoma Metastases
Abstract Presenter: Christine A. Tran, MD – University of Virginia Health
8:19 AM – 8:21 AM CST

A10: Q&A
Abstract Presenter: Christine A. Tran, MD – University of Virginia Health
8:21 AM – 8:29 AM CST

A8: A Simplified Prognostic Classification System for in Transit Melanoma Metastases to Aid Treatment Planning
Abstract Presenter: Clare Peterson, MRes – Norwich Medical School
8:29 AM – 8:31 AM CST

A8: Q&A
Abstract Presenter: Clare Peterson, MRes – Norwich Medical School
8:31 AM – 8:39 AM CST

A15: The Identification of Clinically Relevant Primary Endpoints for Research for in Transit Melanoma Metastases
Abstract Presenter: Clare Peterson, MRes – Norwich Medical School
8:39 AM – 8:41 AM CST

A15: Q&A
Abstract Presenter: Clare Peterson, MRes – Norwich Medical School
8:41 AM – 8:49 AM CST

A11: Disease Progression and Trends in the Management of in Transit Melanoma
Abstract Presenter: Kristen E. Rhodin, MD – Duke University Medical Center
8:49 AM – 8:51 AM CST

A11: Q&A
Abstract Presenter: Kristen E. Rhodin, MD – Duke University Medical Center
8:51 AM – 8:59 AM CST

A12: Functional Assessment of Sentinel Lymph Nodes in Melanoma: Implications for Immune Competence
Abstract Presenter: Mark B. Faries, MD – The Angeles Clinic and Research Institute/ Cedars-Sinai Medical Center
8:59 AM – 9:01 AM CST

A12: Q&A
Abstract Presenter: Mark B. Faries, MD – The Angeles Clinic and Research Institute/ Cedars-Sinai Medical Center
9:01 AM – 9:09 AM CST

A14: Real-world Adherence to Nodal Surveillance for Sentinel Lymph Node Positive Melanoma Patients
Abstract Presenter: Kelsey B. Montgomery, MD – University of Alabama at Birmingham
9:09 AM – 9:11 AM CST

A14: Q&A
Abstract Presenter: Kelsey B. Montgomery, MD – University of Alabama at Birmingham
9:11 AM – 9:19 AM CST

A9: A Systematic Review of Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy
Abstract Presenter: Danielle K. DePalo, MD – Moffitt Cancer Center
9:19 AM – 9:21 AM CST

A9: Q&A
Abstract Presenter: Danielle K. DePalo, MD – Moffitt Cancer Center
9:21 AM – 9:31 AM CST

A16: Utilization of Surgery for Stage 4 Melanoma in the Immunotherapy Era
Abstract Presenter: Thinzar M. Lwin, MD, MS – Dana Farber Cancer Institute
9:31 AM – 9:40 AM CST

A16: Q&A
Abstract Presenter: Thinzar M. Lwin, MD, MS – Dana Farber Cancer Institute